Brigham and Women's Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Brigham and Women's Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its program spans prostate and genitourinary cancers, artificial intelligence in real-world cancer care and surgery after neoadjuvant immunotherapy in head and neck cancer. Other sessions look at clinical benefit, the timing of health technology assessment decisions and cancer drug prices across Europe.
| Organization | ESMO 2026 Attendance |
|---|---|
Brigham and Women's Hospital Boston, MA | |
Teaching hospital of Harvard Medical School in Boston, Massachusetts, with a cancer centre and pharmacoepidemiology research. | Chair Fri Oct 23 13:30–15:00 Rapid oral: Genitourinary tumours, prostate, penile and testils Genitourinary cancersGastrointestinal cancers Abstract Fri Oct 23 14:39–14:51 Invited Discussant 2221RO, 2222RO and LBA56 Genitourinary cancersGastrointestinal cancers Talk Sun Oct 25 10:30–10:45 Abstract Sun Oct 25 10:53–11:03 Talk Mon Oct 26 16:45–17:00 Evolving surgical strategies after neoadjuvant immunotherapy: What should change? Sarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Brigham and Women's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction